Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Sep;80(1):173–177. doi: 10.1111/j.1476-5381.1983.tb11063.x

Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats.

A R Green, P Johnson, V L Nimgaonkar
PMCID: PMC2044967  PMID: 6228277

Abstract

Following electroconvulsive shock (ECS) administration daily for 10 days there was an increase (35%) in 5-hydroxytryptamine2 (5-HT2) receptor number in rat frontal cortex 24 h after the last ECS, compared with handled controls. A similar increase was seen after intermittent ECS administration (5 ECS over 10 days) given during halothane anaesthesia, compared with halothane-treated controls. The dissociation constant was also increased at this time. A single ECS had no effect. Treatment of rats with pentylenetetrazol, p-chlorophenylalanine or alpha-methyl p-tyrosine during the intermittent ECS administration abolished the increase in 5-HT2 receptor binding. Since enhanced 5-HT-mediated behavioural responses are seen after repeated ECS but not when the ECS is given with the drug treatments outlined above, it is suggested that ECS-induced enhancement of 5-HT-mediated behaviour results from an increase in 5-HT2 receptor number.

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacopoulos N. G. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies. J Pharmacol Exp Ther. 1981 Dec;219(3):708–714. [PubMed] [Google Scholar]
  2. Costain D. W., Green A. R., Grahame-Smith D. G. Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy. Psychopharmacology (Berl) 1979 Mar 22;61(2):167–170. doi: 10.1007/BF00426732. [DOI] [PubMed] [Google Scholar]
  3. Cowen P. J., Nutt D. J., Green A. R. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Neuropharmacology. 1980 Sep;19(9):901–906. doi: 10.1016/0028-3908(80)90091-x. [DOI] [PubMed] [Google Scholar]
  4. Deakin J. F., Green A. R. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats. Br J Pharmacol. 1978 Oct;64(2):201–209. doi: 10.1111/j.1476-5381.1978.tb17290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans J. P., Grahame-Smith D. G., Green A. R., Tordoff A. F. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br J Pharmacol. 1976 Feb;56(2):193–199. doi: 10.1111/j.1476-5381.1976.tb07442.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Green A. R., Costain D. W., Deakin J. F. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--III. The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses. Neuropharmacology. 1980 Sep;19(9):907–914. doi: 10.1016/0028-3908(80)90092-1. [DOI] [PubMed] [Google Scholar]
  7. Green A. R., Heal D. J., Grahame-Smith D. G. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology (Berl) 1977 Apr 29;52(2):195–200. doi: 10.1007/BF00439110. [DOI] [PubMed] [Google Scholar]
  8. Green A. R., O'Shaughnessy K., Hammond M., Schächter M., Grahame-Smith D. G. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone. Neuropharmacology. 1983 May;22(5):573–578. doi: 10.1016/0028-3908(83)90147-8. [DOI] [PubMed] [Google Scholar]
  9. Green A. R., Sant K., Bowdler J. M., Cowen P. J. Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock. Neuropharmacology. 1982 Oct;21(10):981–984. doi: 10.1016/0028-3908(82)90110-1. [DOI] [PubMed] [Google Scholar]
  10. Jacobs B. L., Klemfuss H. Brain stem and spinal cord mediation of a serotonergic behavioral syndrome. Brain Res. 1975 Dec 19;100(2):450–457. doi: 10.1016/0006-8993(75)90500-4. [DOI] [PubMed] [Google Scholar]
  11. Kellar K. J., Cascio C. S., Butler J. A., Kurtzke R. N. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol. 1981 Feb 19;69(4):515–518. doi: 10.1016/0014-2999(81)90460-x. [DOI] [PubMed] [Google Scholar]
  12. Lebrecht U., Nowak J. Z. Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain--II. Behavioural studies. Neuropharmacology. 1980 Nov;19(11):1055–1061. doi: 10.1016/0028-3908(80)90101-x. [DOI] [PubMed] [Google Scholar]
  13. Peroutka S. J., Snyder S. H. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981 Mar 16;208(2):339–347. doi: 10.1016/0006-8993(81)90562-x. [DOI] [PubMed] [Google Scholar]
  14. Rosenfeld M. R., Makman M. H. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain. J Pharmacol Exp Ther. 1981 Mar;216(3):526–531. [PubMed] [Google Scholar]
  15. Vetulani J., Lebrecht U., Pilc A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur J Pharmacol. 1981 Nov 19;76(1):81–85. doi: 10.1016/0014-2999(81)90012-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES